Federal Register / Vol. 79, No. 208 / Tuesday, October 28, 2014 / Notices 64205 

Time: 10:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, Suite 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Isis S. Mikhail, MPH, 

DRPH, National Institute on Aging, Gateway 

Building, 7201 Wisconsin Avenue, Suite 

2C212, Bethesda, MD 20892, 301–402–7702, 

Mikhaili@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: October 22, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–25506 Filed 10–27–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Prevention Innovation 

Program (PIP) R01. 

Date: November 14, 2014. 

Time: 9:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Uday K. Shankar, Ph.D., 

MSC, Scientific Review Officer, Scientific 

Review Program, DEAS/NIAID/NIH/DHHS, 

6700B Rockledge Drive, MSC 7616, Bethesda, 

MD 20892–7616, 301–594–3193, 

uday.shankar@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Innovation for Vaccine 

Discovery (R01). 

Date: November 18, 2014. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Room 

CC LD30B, 5601 Fishers Lane, Rockville, MD 

20852 (Telephone Conference Call). 

Contact Person: Dharmendar Rathore, 

Ph.D., Senior Scientific Review Officer, 

Scientific Review Program, Division of 

Extramural Activities, National Institutes of 

Health/NIAID, 5601 Fishers Lane, Bethesda, 

MD 20892, 301–435–2766, rathored@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 22, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–25510 Filed 10–27–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, NIAID Peer Review Meeting. 

Date: November 21, 2014. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 5601 

Fisher Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Brenda Lange-Gustafson, 

Ph.D., Scientific Review Officer, NIAID/NIH/ 

DHHS, Scientific Review Program, Room 

3122, 5601 Fisher Lane, Rockville, MD 20892 

bgustafson@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 22, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–25511 Filed 10–27–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer at (240) 276– 

1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: Partnerships for 

Success Program Evaluation for 

Prevention Contract—New 

SAMHSA is conducting a cross-site 

evaluation of the Strategic Prevention 

Framework (SPF) Partnerships for 

Success (PFS) program, focusing on the 

PFS II cohort (first funded in 2012), PFS 

2013 cohort (first funded in 2013), and 

PFS 2014 cohort (first funded in 2014) 

at both the grantee and community 

subrecipient levels. Grantees include 

states, jurisdictions, and tribal entities 

that subsequently fund community 

subrecipients to implement substance 

use prevention interventions. The 

overall goals of these SPF PFS cohorts 

is to prevent the onset and reduce the 

progression of substance abuse, 

prioritizing underage drinking (UAD) 


asabaliauskas on DSK4SPTVN1PROD with NOTICES